News Focus
News Focus
Post# of 257257
Next 10
Followers 842
Posts 122795
Boards Moderated 10
Alias Born 09/05/2002

Re: RockRat post# 115819

Wednesday, 03/16/2011 8:27:23 AM

Wednesday, March 16, 2011 8:27:23 AM

Post# of 257257
AMLN/Takeda halt phase-2 obesity trial for safety reasons:

http://finance.yahoo.com/news/Amylin-and-Takeda-Voluntarily-prnews-3297796689.html?x=0&.v=1

The trial had been testing the combination of Symlin and metreleptin.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now